COVID-19 Infusion Therapy HCPCS Code range Q0220-Q0249
The HCPCS codes range COVID-19 Infusion Therapy Q0220-Q0249 is a standardized code set necessary for Medicare and other health insurance providers to provide healthcare claims.
Subscribe to Codify by ÐÇ¿ÕÈë¿Úand get the code details in a flash.
Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, 1 mg